2024 Medical Device Investment Data: A Brighter Exit Path, A Challenging Funding Road
Avio’s friends at Nocturnal wrote a great post on medtech funding in 2024 and what that could mean for 2025. Avio’s take? The pickup in M&A and (brief) return of IPOs are positives. Challenges with NIH funding, the FDA, and economic uncertainty are negatives. But you knew that already! What to do? Spend small money…